Oxygenta Pharmaceutical Cash Flow Annual

Trade
BSE: 524636 | NSE: - | ISIN: INE102E01018 | Sector: Biotechnology & Drugs
74.80 +1.70 (2.33%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line -13.87-11.37-0.493.14
Depreciation/ Depletion 2.662.051.591.20
Non- Cash Items 1.651.480.921.76
Changesin Working Capital -3.496.40-3.58-7.51
Cashfrom Operating Activities -13.05-1.63-1.68-1.62
Capital Expenditures -4.11-9.64-4.95-6.74
Other Investing Cash Flow Items Total 0.020.010.000.02
Cashfrom Investing Activities -4.09-9.64-4.94-6.72
Financing Cash Flow Items -1.03-1.49-0.92-1.78
Issuance( Retirement)of Stock Net 28.920.004.00-
Issuance( Retirement)of Debt Net -10.7612.713.2610.45
Cashfrom Financing Activities 17.1311.226.338.67
Net Changein Cash -0.01-0.05-0.290.33
Cash Interest Paid 1.591.490.921.78
Deferred Taxes --1.98-1.21-2.14
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts